Pharmatek Laboratories has been approved by the U.S. Drug Enforcement Agency (DEA) for the analysis of Schedules I through V controlled substances, adding to its existing license to develop and manufacture drug products containing Schedules IV and V controlled substances. “Receipt of this additional registration from the DEA demonstrates that we meet the Agency’s stringent requirements, and further validates our facility design, security systems, and procedures for analysis, handling, storage...